SynthesisMolecular & cellular proteomics : MCP2025
Properties, Origin, and Consistency of Truncated Proteoforms Across Top-Down Proteomic Studies.
Synthesis in Molecular & cellular proteomics : MCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Top-Down versus Bottom-Up Proteomics in Highly Sensitive LC-MS-Based Profiling of Limited Samples.Analytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Protein truncation is a common modification that can alter protein localization, interaction, activity, and function. Top-down proteomics targets the identification of all molecular forms in which a protein can exist (termed "proteoforms") and is thus well-suited for termini analysis. To examine the properties, origin, and consistency of truncated proteoforms, we performed a meta-analysis of 50 top-down proteomics datasets published over the past decade, covering 140,000 proteoforms derived from 14,500 proteins across various species. On average across all datasets, approximately 71% of proteoforms were truncated, with the vast majority not yet being documented in protein databases. Our analysis was able to distinguish between artificial truncations (e.g., sample preparation effects on labile peptide bonds) and endogenous truncations, enabling the identification of novel signal peptides and truncations between structured domains. This study highlights the importance of a common yet understudied mechanism for generating protein diversity and provides a valuable resource for future studies, targeting truncated proteoform functions or aiming to reduce artefacts in proteomics sample preparation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.